Stay updated on Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision: v3.5.0 was added and v3.4.3 was removed.SummaryDifference0.1%

- Check28 days agoChange DetectedThe page's revision tag was updated from v3.4.2 to v3.4.3, indicating an updated version of the content.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page now shows Revision: v3.4.2 and the older notices including the government funding lapse notice and Revision: v3.4.1 have been removed.SummaryDifference0.5%

- Check64 days agoChange DetectedAdded a government funding notice about potential delays and site status, and bumped the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedAdded 'Show glossary' and updated the study results section to display 'Results First Posted' (replacing the 'Estimated' variant), along with 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', and updated the No FEAR Act data labeling and the site revision to v3.4.0.SummaryDifference0.4%

- Check85 days agoChange DetectedAdded a Revision: v3.3.4 and removed Revision: v3.3.3. This appears to be a metadata/version update with no impact on the study details or user actions.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial page.